GGrantIndex
Sort

50,496 grants matching lung cancer

Targeting epithelial membrane protein 2 (EMP2) in retinopathy of prematurity

$405,647
Alison Chu · University Of California Los Angeles · R01 · FY2021 · EY

Molecular Basis of Endoderm Development

$405,638
Aaron M Zorn · Cincinnati Childrens Hosp Med Ctr · R01 · FY2006 · HD

Pulmonary Development: Molecular & Cellular Analysis

$405,625
Parviz Minoo Minoo · University Of Southern California · R01 · FY2010 · HL

Modulation of Viral Antigen Presentation in the Lung

$405,600
Anna Karolina Palucka · Jackson Laboratory · U19 · FY2021 · AI

Brilliant epitopes for improved cancer vaccines

$405,599
David K. Gifford · Think Therapeutics, Inc. · R43 · FY2025 · CA

Whole Genome Scan for Pancreatic Cancer Risk in the Pancreatic Cancer CohortCons

$405,572
Rachael Stolzenberg-Solomon · Division Of Cancer Epidemiology And Genetics · ZIA · FY2009 · CA

Pilot Project Program

$405,531
Rebecca A Simmons · University Of Pennsylvania · P30 · FY2023 · ES

Nrf2 and Radiation-induced pulmonary fibrosis.

$405,505
Michael L. Freeman · Vanderbilt University Medical Center · R01 · FY2016 · HL

Targeting metastatic tumors with engineered cellular therapies

$405,478
Khalid A Shah · Brigham And Women'S Hospital · R01 · FY2023 · CA

Markers of Cardiotoxicity with Radiation Therapy in Breast Cancer

$405,461
Bonnie Ky · University Of Pennsylvania · R01 · FY2021 · HL

The Role of Akt in Cell Survival and Cell Growth

$405,451
Nissim Hay · University Of Illinois At Chicago · R01 · FY2014 · AG

Identification of potentially active tyrosine kinases in lung cancer

$405,432
Udayan Guha · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA

Project 2

$405,310
Jeroen Roose · University Of California, San Francisco · P01 · FY2020 · AI

Understanding T cell responses and T cell signaling in human airway organoids with SARS-CoV-2 infection

$405,310
Arthur Weiss · University Of California, San Francisco · P01 · FY2020 · AI

Atlases to Report and Correlate Radiotherapy Dose Distributions with Outcomes

$405,304
Andrew Jackson · Sloan-Kettering Inst Can Research · R01 · FY2013 · CA

Development Of Drugs Acting At Adenosine Receptors

$405,261
Kenneth Alan Jacobson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2013 · DK

SWOG Community Clinical Oncology Program Research Base

$405,248
Charles D. Blanke · Oregon Health & Science University · U10 · FY2013 · CA

Translational regulation during cigarette smoking-induced reprogramming of the tRNA epitranscriptome, in vitro and in a mouse smoking model

$405,240
Thomas J Begley · State University Of New York At Albany · R01 · FY2020 · ES

The Role of the Nicotinic Cholinergic Pathway in Retinopathy of Prematurity

$405,202
John P Cooke · Stanford University · R01 · FY2012 · EY

Cancer Cell Intrinsic Interferon-I pathway Activation by Fractionated Radiation

$405,180
Sandra Demaria · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · CA

Targeting PKR-Bcl2 Signaling to Overcome Paclitaxel Resistance in Ovarian Cancer

$405,163
Jixin Dong · University Of Nebraska Medical Center · R01 · FY2023 · CA

Targeting EGFR and KRAS Mutations

$405,161
Harold E Varmus · Sloan-Kettering Inst Can Research · P01 · FY2008 · CA

Individualized in situ vaccination by radiation and immunotherapy

$405,106
Sandra Demaria · Weill Medical Coll Of Cornell Univ · R01 · FY2016 · CA

Cohort Study of Genetic Susceptibility to Breast Cancer

$405,093
David John Hunter · Brigham And Women'S Hospital · R01 · FY2007 · CA

Synergistic Immunosuppression by PAHs and Arsenite

$405,089
Scott W Burchiel · University Of New Mexico Health Scis Ctr · R01 · FY2014 · ES